Isolation and genome characterization of SARS-CoV-2 recombinant Omicron variant XBB.1.16 from Central India
VirusDisease · 2026-09 · 37 (3) · 296-303
DOI: 10.1007/s13337-026-00974-w ↗Kurz gefasst
Fachartikel in der Zeitschrift VirusDisease, online erschienen am 22.07.2026. Verfasst von Rohit Menon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Virology, Defence Research & Development Establishment (DRDE), Jhansi Road, Gwalior, 474002 India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: defence research and development organisation, India.
Abstract (Originalsprache)
Despite the World Health Organization's declaration in May 2023 of the end of the Public Health Emergency of International Concern (PHEIC), COVID-19 continues to circulate globally. As such, the continued transmission across the different parts of the globe resulted in the emergence of variants which could pose a constant challenge to public health. The isolation of circulating virus variants during these times is essential to assess the impact of the strains and establish effective counter-measures if necessary. This study focuses on the isolation and characterization of the SARS-CoV-2 recombinant Omicron variant XBB.1.16 from a clinical sample in Central India, collected during an early 2023 surge. Using a throat swab, confirmation of the variant by qRT-PCR and distinctive Cytopathic Effects (CPE) were observed on the Vero E6 cell line. The isolation by passages of the virus was found to be successful through positive qRT-PCR and next-generation sequencing (NGS). The isolate was found to be XBB.1.16, Clade GRA, a Variant of Interest (VOI) after sequencing. Detailed analysis of the spike gene indicated 53 mutations leading to 45 amino acid substitutions compared to the original Wuhan strain. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s13337-026-00974-w.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Virology, Defence Research & Development Establishment (DRDE), Jhansi Road, Gwalior, 474002 India.
ORCID-Profile: Sushil Kumar Sharma
Förderung
- defence research and development organisation, India
Zitieren
APA
Menon, R., Sharma, S. K., Behera, A., Shrivastava, A., Sharma, S., Kumar, J. S., Dash, P. K., & Parida, M. (2026). Isolation and genome characterization of SARS-CoV-2 recombinant Omicron variant XBB.1.16 from Central India. VirusDisease, 37(3), 296-303. https://doi.org/10.1007/s13337-026-00974-w
Vancouver
Menon R, Sharma SK, Behera A, Shrivastava A, Sharma S, Kumar JS, et al. Isolation and genome characterization of SARS-CoV-2 recombinant Omicron variant XBB.1.16 from Central India. VirusDisease. 2026;37(3):296-303. doi:10.1007/s13337-026-00974-w
BibTeX
@article{Menon2026,
author = {Menon, Rohit and Sharma, Sushil Kumar and Behera, Anshuman and Shrivastava, Ambuj and Sharma, Shashi and Kumar, Jyoti S and Dash, Paban Kumar and Parida, Manmohan},
title = {Isolation and genome characterization of SARS-CoV-2 recombinant Omicron variant XBB.1.16 from Central India},
journal = {VirusDisease},
year = {2026},
volume = {37},
number = {3},
pages = {296--303},
doi = {10.1007/s13337-026-00974-w}
}
EUVIMED